![]() |
|
|
Vol. 286, Issue 2, 952-958, August 1998
Thoracic Medicine, Imperial College School of Medicine at the
National Heart and Lung Institute, Dovehouse Street, London, England
Indirect functional studies suggest that large-conductance
calcium-activated potassium channels (BKCa channels) are
involved in the control of ACh release from postganglionic,
parasympathetic nerve terminals in the airways. The role of
BKCa channels in regulating cholinergic neurotransmission
was assessed by 1) investigating the effect of the putative
BKCa channel opener NS1619 on cholinergic contractile
responses and ACh output evoked by electrical field stimulation (EFS:
40 V, 0.5 ms, 4 Hz for 15 s every 4 min) and comparing the effect
obtained with the inhibition of EFS-evoked ACh release by oxotremorine
M, a muscarinic agonist, and 2) evaluating the sensitivity of these
responses to the BKCa channel blocker iberiotoxin (IbTX).
NS1619 (30 µM) inhibited cholinergic contractile responses by 60.0%.
In contrast, NS1619 had no effect on contractile responses evoked by
exogenous ACh (1 µM), which indicated that it was acting
prejunctionally. NS1619 (30 µM) significantly inhibited EFS-induced
ACh release by 33.9%. Oxotremorine M suppressed EFS-evoked ACh release
in a concentration-dependent manner (at 1 µM, 77.4% inhibition). In
neither case was the inhibition reversed by IbTX (100 nM).
Collectively, the mechanical data suggest that NS1619 inhibits
cholinergic contractile responses by interacting prejunctionally. The
failure of IbTX to reverse the inhibitory action of NS1619 and
oxotremorine M on ACh release indicates that activation of muscarinic
autoinhibitory receptors is not coupled to the opening of
IbTX-sensitive BKCa channels. Therefore, we propose that
caution be exercised when using NS1619 as an activator of
BKCa channels.